F10 and hemophilia: The aPCC products contain clotting factors, such as FIX/FIXa, FX/FXa, and FII/thrombin, which enhance coagulation potential, and our data showed that measurements of thrombin generation were within the normal range in AT-reduced plasma of people with hemophilia in the presence of 25 to 50 IU/kg aPCC.